S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Critical asset just had biggest fall on record (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Critical asset just had biggest fall on record (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Critical asset just had biggest fall on record (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Critical asset just had biggest fall on record (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Critical asset just had biggest fall on record (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Critical asset just had biggest fall on record (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Critical asset just had biggest fall on record (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Critical asset just had biggest fall on record (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
Google says its AI image-generator would sometimes 'overcompensate' for diversity

Atea Pharmaceuticals (AVIR) News Today

$4.20
+0.17 (+4.22%)
(As of 02/23/2024 ET)
SourceHeadline
finance.yahoo.com logoAtea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
finance.yahoo.com - February 21 at 8:06 AM
globenewswire.com logoAtea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
globenewswire.com - February 21 at 7:00 AM
stockhouse.com logoSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Atea Pharmaceuticals, Inc. (AVIR) and Encourages Investors to Contact the Firm
stockhouse.com - February 13 at 9:29 AM
marketbeat.com logoAtea Pharmaceuticals, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.66) Per Share (NASDAQ:AVIR)
marketbeat.com - February 7 at 8:07 AM
marketbeat.com logoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) CAO Sells $47,911.68 in Stock
marketbeat.com - February 3 at 12:22 AM
marketbeat.com logoShort Interest in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Expands By 7.1%
marketbeat.com - January 15 at 5:48 PM
finance.yahoo.com logoAtea Pharma (AVIR) Gains on Upbeat Initial Data From HCV Study
finance.yahoo.com - January 10 at 12:55 PM
msn.com logoAtea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy
msn.com - January 9 at 3:36 PM
msn.com logoAtea gains after mid-stage data for lead asset in Hepatitis C
msn.com - January 9 at 3:36 PM
finance.yahoo.com logoAtea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19
finance.yahoo.com - January 8 at 6:17 PM
morningstar.com logoAtea Pharmaceuticals Inc Ordinary Shares
morningstar.com - January 6 at 11:28 PM
morningstar.com logoAtea Pharmaceuticals Inc Ordinary Shares
morningstar.com - January 6 at 11:28 PM
finance.yahoo.com logoAtea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 7:52 AM
marketbeat.com logoBML Capital Management LLC Grows Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - January 1 at 8:08 AM
finance.yahoo.com logoAtea Pharmaceuticals Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
finance.yahoo.com - November 13 at 8:20 AM
finance.yahoo.com logoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 9 at 7:57 PM
finance.yahoo.com logoQ3 2023 Atea Pharmaceuticals Inc Earnings Call
finance.yahoo.com - November 9 at 9:56 AM
msn.com logoAtea Pharmaceuticals GAAP EPS of -$0.40
msn.com - November 8 at 7:05 PM
finance.yahoo.com logoAtea Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 8 at 7:05 PM
finance.yahoo.com logoAtea Pharmaceuticals Announces Participation at Upcoming Investor Conferences
finance.yahoo.com - November 8 at 8:59 AM
msn.com logoAtea Pharmaceuticals Q3 2023 Earnings Preview
msn.com - November 8 at 1:04 AM
benzinga.com logoAtea Pharmaceuticals's Earnings Outlook
benzinga.com - November 7 at 3:03 PM
finance.yahoo.com logoAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
finance.yahoo.com - November 2 at 8:00 AM
finance.yahoo.com logoAtea Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call on November 8, 2023
finance.yahoo.com - November 1 at 10:32 AM
marketbeat.com logoAuour Investments LLC Acquires New Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - September 15 at 11:15 AM
marketbeat.com logoMartingale Asset Management L P Sells 176,185 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - September 8 at 5:28 AM
finance.yahoo.com logoAtea Pharmaceuticals to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
finance.yahoo.com - September 6 at 8:16 AM
marketbeat.com logoNew York Life Investment Management LLC Has $487,000 Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - August 15 at 5:45 AM
marketbeat.com logoFederated Hermes Inc. Has $6.83 Million Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - August 14 at 5:37 AM
marketbeat.com logoQ3 2023 EPS Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Increased by William Blair
marketbeat.com - August 14 at 2:46 AM
marketbeat.com logoLeerink Partnrs Comments on Atea Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:AVIR)
marketbeat.com - August 11 at 9:44 AM
msn.com logoJP Morgan Downgrades Atea Pharmaceuticals (AVIR)
msn.com - August 11 at 12:18 AM
finance.yahoo.com logoQ2 2023 Atea Pharmaceuticals Inc Earnings Call
finance.yahoo.com - August 9 at 7:51 AM
msn.com logoAtea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15
msn.com - August 8 at 9:42 PM
finance.yahoo.com logoAtea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - August 8 at 4:42 PM
benzinga.com logoEarnings Preview For Atea Pharmaceuticals
benzinga.com - August 8 at 11:21 AM
finance.yahoo.com logoAtea Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023
finance.yahoo.com - August 1 at 4:25 PM
marketbeat.com logoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Strs Ohio
marketbeat.com - July 28 at 4:08 AM
marketbeat.com logoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Sees Significant Decrease in Short Interest
marketbeat.com - July 21 at 3:03 AM
uk.finance.yahoo.com logoAVIR - Atea Pharmaceuticals, Inc.
uk.finance.yahoo.com - July 6 at 9:07 PM
marketbeat.com logoVontobel Holding Ltd. Grows Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
marketbeat.com - June 29 at 4:26 AM
fool.com logoAtea Pharmaceuticals (NASDAQ: AVIR)
fool.com - June 27 at 9:56 AM
marketwatch.com logo8-K: Atea Pharmaceuticals, Inc.
marketwatch.com - June 22 at 3:00 PM
finance.yahoo.com logoAtea Pharmaceuticals Announces First Patient Dosed in Phase 2 Study for Treatment of Hepatitis C with Bemnifosbuvir and Ruzasvir Combination
finance.yahoo.com - June 15 at 8:42 AM
marketbeat.com logo56,920 Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Bought by GSA Capital Partners LLP
marketbeat.com - June 12 at 10:41 AM
finance.yahoo.com logoAtea Pharmaceuticals to Present at the Jefferies Healthcare Conference
finance.yahoo.com - June 5 at 5:54 PM
marketwatch.com logoAtea Pharmaceuticals Rejects Buyout Offer
marketwatch.com - May 30 at 8:55 AM
markets.businessinsider.com logoAtea Pharma Rejects Unsolicited Proposal From Tang Capital Partners
markets.businessinsider.com - May 30 at 8:55 AM
finance.yahoo.com logoAtea Pharmaceuticals’ Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
finance.yahoo.com - May 30 at 8:55 AM
finanznachrichten.de logoAtea Pharmaceuticals, Inc.: Atea Pharmaceuticals Confirms Receipt of Unsolicited Proposal from Tang Capital Partners' Affiliate, Concentra Biosciences
finanznachrichten.de - May 24 at 10:21 AM
Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.



AVIR Media Mentions By Week

AVIR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVIR
News Sentiment

0.38

0.43

Average
Medical
News Sentiment

AVIR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVIR Articles
This Week

2

1

AVIR Articles
Average Week

Get Atea Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVIR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AVIR) was last updated on 2/24/2024 by MarketBeat.com Staff